New CEOs at Aro and Navigator

Purnanand Sarma will become CEO of Aro Biotherapeutics Co., succeeding co-founder Susan Dillon, who will continue as chair and become an adviser to the company. Sarma was CEO of Taris Biomedical Inc. and Immunome Inc. Aro is developing a pipeline of small, stable, soluble proteins to deliver conjugated drug payloads via the addition of antigen-specific binding sites.

Navigator Medicines Inc. named Tausif “Tosh” Butt CEO and Khuren Farooq chairman. Butt was president of Idorsia Ltd. (SIX:IDIA), and Farooq is CEO of Verdiva Bio Ltd. Navigator is developing a bispecific to treat inflammatory diseases...